by John A. Jenkins | Jun 6, 2024 | FDA, FOIA, Law Firms, Litigation, Medical Devices
FOIAengine: Hundreds of FOIA Requests Signaled Challenge to FDA Two companies that go by the names of Triton Distribution and Vapetasia are small players in America’s fast-growing $28 billion e-cigarette market. Despite their size, they’ve become the unlikely...
by John A. Jenkins | Apr 3, 2024 | FDA, FOIA, Law Firms, Medical Devices
FOIAengine: Neuralink’s High Profile Makes It a Target It was a Musk Moment unlike any other: Two weeks ago, the first human participant in Neuralink’s brain-implant trials took the stage to show how he could play chess by imagining where he wanted the pieces to go. ...
by Randy E. Miller | Mar 27, 2024 | FDA, FOIA, Hedge Funds, Law Firms, Litigation, Non-Profits, Pharmaceuticals, Politics, Short-Selling, Stock Market
FOIAengine: Conservative Activists, Law Firms, Non-Profits Signal Competing Agendas A review of the most recent Freedom of Information Act requests made to the Food and Drug Administration illustrates how political organizations, law firms, news media, and financial...
by John A. Jenkins | Mar 13, 2024 | FDA, FOIA, Law Firms, Non-Profits, Pharmaceuticals
FOIAengine Spotlights a Non-Profit Newsroom and Another Problem for the FDA The Food and Drug Administration was already under fire from Congress and others after hundreds of toddlers in 44 states were poisoned last year by lead-tainted pouches of apple puree and...
by Randy E. Miller | Jan 24, 2024 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals
In FOIAengine, a Law Firm’s Strategy Takes Shape When we tallied the hundreds of thousands of Freedom of Information Act requests filed with the federal government last year, one law firm stood out. According to PoliScio Analytics’ competitive-intelligence database...
by John A. Jenkins | Jan 10, 2024 | Antitrust, FOIA, FTC, Law Firms, Litigation
Requests in FOIAengine Show Groups Watching the FTC When the Federal Trade Commission joined the Justice Department last month in announcing new merger guidelines, two years in the making, the revised rules of the road were a warning to acquisitive corporations: ...
